Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies
Cancers - Switzerland
doi 10.3390/cancers11091382
Full Text
Open PDFAbstract
Available in full text
Date
September 17, 2019
Authors
Publisher
MDPI AG